Eloquest Healthcare

What Eloquest Healthcare does

Eloquest Healthcare, Inc. is a U.S. medical device company that develops and sells clinically-validated products for vascular access securement, infection prevention, and related acute care applications. The company is headquartered in Ferndale, Michigan and operates as a wholly owned subsidiary of Ferndale Pharma Group, Inc., with core product trademarks held by Ferndale IP, Inc. Its five-product portfolio comprises Mastisol Liquid Adhesive (a gum mastic adhesive to enhance PIVC and CVC dressing adherence), Detachol Adhesive Remover (a non-alcohol/acetone remover to prevent MARSI), SecurAcath (a subcutaneous anchor securement device for 3Fr–12Fr catheters, distributed under agreement with Interrad Medical), LMX4 Topical Anesthetic Cream (for dermal pain reduction during vascular access procedures), and OMNI-STAT Hemostatic Agent (for rapid hemorrhage control).

The business is built around a niche acute care clinical problem set: preventing catheter-related bloodstream infections (CLABSI/CRBSI), catheter dislodgement, dressing disruption, and medical adhesive-related skin injuries. Eloquest backs its claims with a substantial clinical evidence library including the STICKY randomized controlled trial, the SECURED Superiority Trial published in JAMA Pediatrics, and the Clatterbridge SecurAcath study covering over 1.2 million catheter days, and Mastisol is recommended in the Standards of Care for PIVC: Evidence-Based Expert Consensus.

Eloquest generates revenue through direct sale of proprietary medical devices to hospitals and healthcare facilities, primarily via a field sales force conducting on-site trials, clinical education, and vascular access device site audits. Pricing is quote-based and not publicly disclosed. The company supplements direct sales with a structured clinical-education and thought-leadership marketing program: the "3 Questions With" video series, sponsored I Save That webinars in partnership with the Association for Vascular Access (AVA), and active participation at APIC, AVA Annual Scientific Meetings, IP Director Summits, and healthcare materials management conferences. A consumer-accessible Amazon storefront extends distribution for select SKUs. Target customers include acute care hospitals, trauma centers, children's hospitals, infection preventionists, and vascular access specialists across the United States.

Name

Eloquest Healthcare

Legal name

Eloquest Healthcare, Inc.

Website

https://eloquesthealthcare.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

Eloquest Healthcare is a U.S. medical device company serving acute care hospitals with clinically-validated products for vascular access securement, infection prevention, and wound care, including Mastisol Liquid Adhesive, SecurAcath, Detachol, and LMX4. The company is a wholly owned subsidiary of Ferndale Pharma Group.

Ownership category

akta.pro rank

Product category

Medical Devices for Vascular Access and Infection Prevention

NAICS

Surgical Appliance and Supplies Manufacturing (339113), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (423450)

SIC

Surgical & Medical Instruments & Apparatus (3841), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets) (HLAHADAL)

akta.pro secondary industries

First Aid & Wound Care (Bandages, Dressings, Antiseptics, Burn Care) (CRADAMAB), Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Vascular access devices
• Infection prevention products
• Medical adhesive solutions
• Catheter securement devices
• Acute care medical supplies

Headquarters

HQ city

Ferndale

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Operations, Technology or R&D

Revenue model

1. Medical Device and Healthcare Product Sales: Eloquest Healthcare generates revenue through the sale of proprietary medical devices and healthcare products including Mastisol Liquid Adhesive, Detachol Adhesive Remover, SecurAcath, LMX4 Topical Anesthetic Cream, and OMNI-STAT Hemostatic Agent to hospitals and healthcare facilities.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels7 records

Core offering

Eloquest Healthcare sells a portfolio of branded medical devices and topical products for acute care hospitals, including Mastisol® Liquid Adhesive (dressing securement), Detachol® Adhesive Remover (gentle adhesive removal), LMX4® Topical Anesthetic Cream (dermal pain reduction), SecurAcath® Subcutaneous Anchor Securement (catheter securement), and OMNI-STAT® Hemostatic Agent (hemorrhage control). The portfolio is positioned to reduce catheter-related bloodstream infections, dressing disruption, MARSI, and dislodgement across vascular access workflows.

Product overview

Eloquest Healthcare is a medical device company offering a portfolio of clinically-proven products focused on vascular access and infection prevention. The core product lineup includes Mastisol® Liquid Adhesive (for dressing securement), Detachol® Adhesive Remover (for gentle adhesive removal), LMX4® Topical Anesthetic Cream (for pain reduction), SecurAcath® (subcutaneous anchor securement device), and OMNI-STAT Hemostatic Agent (for hemorrhage control). These products work together to help clinicians enhance catheter securement, reduce hospital-acquired infections, improve patient comfort, and lower healthcare costs.

Differentiator

Problem solved

Functional benefit

Products and services

• Mastisol® Liquid Adhesive Medical liquid adhesive (gum mastic) applied around dressing edges to enhance securement and prevent catheter-related bloodstream infections. Clinically proven to prevent PIVC dressing disruption.
• Detachol® Adhesive Remover Non-irritating adhesive remover that gently breaks down adhesive bonds without alcohol or acetone, helping prevent MARSI and enabling pain-free removal of medical devices including CGM sensors and vascular access dressings.
• LMX4® Topical Anesthetic Cream Topical anesthetic cream for reducing dermal pain associated with medical procedures including vascular access device insertion and adhesive removal.
• SecurAcath® Subcutaneous Anchor Securement Subcutaneous anchor securement device for catheters and drains (3Fr-12Fr) that provides consistent securement without sutures, eliminating needlestick injury risk and maintaining grip for the duration of need.
• OMNI-STAT® Hemostatic Agent Hemostatic gauze (4x4) designed for rapid hemorrhage control in hospital settings, providing quick bleeding cessation for trauma and acute care applications.

Quantifiable outcome

• Improved dressing integrity: intact dressings increased from 60% to 93% after gum mastic adoption
• +3 more outcomes

Named customers4 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Four partnerships are on record, tiered core and minor.

• Ferndale Pharma Group, Inc.coreStrategic or Co-development PartnerEloquest Healthcare is a wholly owned subsidiary of Ferndale Pharma Group, Inc., focused specifically on serving hospitals, their healthcare practitioners, and patients. Ferndale IP, Inc. holds the trademarks for Eloquest Healthcare products.
• Interrad Medical, Inc.coreTechnology or IntegrationEloquest Healthcare distributes SecurAcath®, a subcutaneous anchor securement device manufactured by Interrad Medical, Inc. SecurAcath is a registered trademark of Interrad Medical, Inc.
• Association for Vascular Access (AVA)coreGTM or Marketing PartnerStrategic partnership involving sponsored webinars (I Save That series), presence at AVA Annual Scientific Meetings, content distribution through AVA Academy, and co-development of educational content. AVA provides CE contact hours for Eloquest-sponsored educational programs.
• Mighty WellminorGTM or Marketing PartnerCo-marketing partnership featuring Emily Levy, Mighty Well co-founder and AVA Director-at-Large, in the '3 Questions With' video series. Mighty Well offers patient-focused medical products including PICCPerfect® Pro.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Smith+Nephew: Smith+Nephew is a global medical device incumbent with wound management and surgical products sold into acute care, comparable to Eloquest's wound-care adjacency.
• Cardinal Health: Cardinal Health distributes medical and surgical supplies to hospitals and health systems, serving as both a distribution and product peer for Eloquest's hospital channel.
• Becton Dickinson (BD): BD is a broad-line incumbent in vascular access, injection, and infection prevention; its Medical segment sells catheter securement, dressings, and skin prep products into the same acute care hospitals Eloquest serves.
• 3M Health Care: 3M's Health Care division supplies wound care dressings, skin adhesives, and securement products to hospitals, overlapping with Eloquest's Mastisol and Detachol product categories as a broad incumbent.
• McKesson: McKesson Medical-Surgical distributes medical supplies and devices to acute care customers, representing a wholesale distribution peer that competes for hospital contracts.
• Baxter International: Baxter offers hospital products including IV therapy, surgical solutions, and hemostatic agents, making it a broad-line peer overlapping with Eloquest's OMNI-STAT and vascular access categories.

Direct peers

• ICU Medical: ICU Medical is a direct competitor in IV therapy, vascular access, and catheter securement, selling a broad line of needlefree connectors, IV sets, and vascular access devices to hospitals — overlapping directly with Eloquest's vascular access focus.
• Teleflex: Teleflex offers a vascular access portfolio including catheter securement, IV therapy, and infection prevention products sold to acute care hospitals — directly comparable to Eloquest's hospital customer base and product categories.

Emerging players

• Ansell: Ansell's healthcare division sells examination gloves, surgical gloves, and infection prevention products to hospitals, an adjacent peer in the HAI prevention space Eloquest targets.

Others

• Interrad Medical: Interrad Medical is the manufacturer of SecurAcath, which Eloquest distributes; included as a strategic partner rather than direct competitor.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/eloquest
• YouTubeyoutube.com/channel/UC-BRL7ochpBN4jqYRBKgMfw
• Facebookfacebook.com/EloquestHealthcareInc
• LinkedInlinkedin.com/company/1811265

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eloquest Healthcare